vs

Side-by-side financial comparison of ASCENT INDUSTRIES CO. (ACNT) and ASSEMBLY BIOSCIENCES, INC. (ASMB). Click either name above to swap in a different company.

ASCENT INDUSTRIES CO. is the larger business by last-quarter revenue ($11.9M vs $10.8M, roughly 1.1× ASSEMBLY BIOSCIENCES, INC.). ASCENT INDUSTRIES CO. runs the higher net margin — -8.8% vs -85.2%, a 76.5% gap on every dollar of revenue. On growth, ASSEMBLY BIOSCIENCES, INC. posted the faster year-over-year revenue change (57.6% vs 13.3%). ASCENT INDUSTRIES CO. produced more free cash flow last quarter ($-196.0K vs $-15.2M).

Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

ACNT vs ASMB — Head-to-Head

Bigger by revenue
ACNT
ACNT
1.1× larger
ACNT
$11.9M
$10.8M
ASMB
Growing faster (revenue YoY)
ASMB
ASMB
+44.3% gap
ASMB
57.6%
13.3%
ACNT
Higher net margin
ACNT
ACNT
76.5% more per $
ACNT
-8.8%
-85.2%
ASMB
More free cash flow
ACNT
ACNT
$15.0M more FCF
ACNT
$-196.0K
$-15.2M
ASMB

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ACNT
ACNT
ASMB
ASMB
Revenue
$11.9M
$10.8M
Net Profit
$-1.0M
$-9.2M
Gross Margin
14.6%
Operating Margin
-21.0%
-100.9%
Net Margin
-8.8%
-85.2%
Revenue YoY
13.3%
57.6%
Net Profit YoY
-1.2%
4.3%
EPS (diluted)
$-0.11
$-0.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACNT
ACNT
ASMB
ASMB
Q4 25
$11.9M
Q3 25
$19.7M
$10.8M
Q2 25
$18.7M
$9.6M
Q1 25
$24.7M
$9.4M
Q4 24
$10.5M
$7.4M
Q3 24
$20.9M
$6.8M
Q2 24
$21.5M
$8.5M
Q1 24
$28.0M
$5.8M
Net Profit
ACNT
ACNT
ASMB
ASMB
Q4 25
$-1.0M
Q3 25
$-2.1M
$-9.2M
Q2 25
$6.3M
$-10.2M
Q1 25
$-2.3M
$-8.8M
Q4 24
$-1.0M
Q3 24
$-6.2M
$-9.6M
Q2 24
$-926.0K
$-11.2M
Q1 24
$-5.5M
$-9.1M
Gross Margin
ACNT
ACNT
ASMB
ASMB
Q4 25
14.6%
Q3 25
29.7%
Q2 25
26.1%
Q1 25
19.3%
Q4 24
24.3%
Q3 24
14.4%
Q2 24
13.1%
Q1 24
8.3%
Operating Margin
ACNT
ACNT
ASMB
ASMB
Q4 25
-21.0%
Q3 25
-4.1%
-100.9%
Q2 25
-14.4%
-115.2%
Q1 25
-4.2%
-105.5%
Q4 24
-25.4%
Q3 24
-9.4%
-160.1%
Q2 24
-8.6%
-143.0%
Q1 24
-15.5%
-185.5%
Net Margin
ACNT
ACNT
ASMB
ASMB
Q4 25
-8.8%
Q3 25
-10.6%
-85.2%
Q2 25
33.7%
-105.9%
Q1 25
-9.3%
-93.6%
Q4 24
-9.8%
Q3 24
-29.5%
-140.4%
Q2 24
-4.3%
-130.7%
Q1 24
-19.7%
-156.9%
EPS (diluted)
ACNT
ACNT
ASMB
ASMB
Q4 25
$-0.11
Q3 25
$-0.22
$-0.72
Q2 25
$0.65
$-1.33
Q1 25
$-0.23
$-1.17
Q4 24
$-0.11
Q3 24
$-0.61
$-1.51
Q2 24
$-0.09
$-1.98
Q1 24
$-0.54
$-1.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACNT
ACNT
ASMB
ASMB
Cash + ST InvestmentsLiquidity on hand
$57.6M
$22.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$87.0M
$182.7M
Total Assets
$111.9M
$240.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACNT
ACNT
ASMB
ASMB
Q4 25
$57.6M
Q3 25
$58.0M
$22.5M
Q2 25
$60.5M
$24.0M
Q1 25
$14.3M
$23.4M
Q4 24
$16.1M
$38.3M
Q3 24
$8.5M
$28.5M
Q2 24
$3.6M
$19.2M
Q1 24
$1.3M
$18.7M
Total Debt
ACNT
ACNT
ASMB
ASMB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACNT
ACNT
ASMB
ASMB
Q4 25
$87.0M
Q3 25
$87.1M
$182.7M
Q2 25
$89.7M
$18.1M
Q1 25
$91.2M
$27.1M
Q4 24
$93.5M
$33.4M
Q3 24
$94.7M
$26.0M
Q2 24
$101.0M
$34.7M
Q1 24
$102.0M
$32.6M
Total Assets
ACNT
ACNT
ASMB
ASMB
Q4 25
$111.9M
Q3 25
$119.9M
$240.0M
Q2 25
$122.6M
$80.8M
Q1 25
$152.5M
$99.0M
Q4 24
$147.3M
$119.2M
Q3 24
$148.6M
$100.3M
Q2 24
$158.2M
$115.3M
Q1 24
$161.0M
$119.9M
Debt / Equity
ACNT
ACNT
ASMB
ASMB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACNT
ACNT
ASMB
ASMB
Operating Cash FlowLast quarter
$266.0K
$-15.1M
Free Cash FlowOCF − Capex
$-196.0K
$-15.2M
FCF MarginFCF / Revenue
-1.7%
-140.7%
Capex IntensityCapex / Revenue
3.9%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACNT
ACNT
ASMB
ASMB
Q4 25
$266.0K
Q3 25
$1.3M
$-15.1M
Q2 25
$-1.4M
$-16.8M
Q1 25
$-700.0K
$-23.4M
Q4 24
$8.8M
$-51.1M
Q3 24
$3.4M
$-15.2M
Q2 24
$2.2M
$-17.1M
Q1 24
$263.0K
$-18.4M
Free Cash Flow
ACNT
ACNT
ASMB
ASMB
Q4 25
$-196.0K
Q3 25
$695.0K
$-15.2M
Q2 25
$-1.5M
Q1 25
$-1.0M
Q4 24
$8.4M
$-51.1M
Q3 24
$3.1M
Q2 24
$1.9M
$-17.1M
Q1 24
$25.0K
$-18.4M
FCF Margin
ACNT
ACNT
ASMB
ASMB
Q4 25
-1.7%
Q3 25
3.5%
-140.7%
Q2 25
-8.3%
Q1 25
-4.1%
Q4 24
80.6%
-695.2%
Q3 24
15.1%
Q2 24
9.1%
-200.6%
Q1 24
0.1%
-317.7%
Capex Intensity
ACNT
ACNT
ASMB
ASMB
Q4 25
3.9%
Q3 25
3.1%
0.4%
Q2 25
0.8%
0.0%
Q1 25
1.3%
0.0%
Q4 24
3.7%
0.4%
Q3 24
1.3%
0.0%
Q2 24
1.0%
0.2%
Q1 24
0.9%
0.2%
Cash Conversion
ACNT
ACNT
ASMB
ASMB
Q4 25
Q3 25
Q2 25
-0.22×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACNT
ACNT

Other$6.1M52%
Transferred At Point In Time$5.7M48%

ASMB
ASMB

Segment breakdown not available.

Related Comparisons